Slide seminar-Hattab - IAP-AD

Report
Scientific Committee of the ADIAP 25th Annual Congress
and the 5th JSP International Conference
Eyas M. Hattab, M.D.
Department of Pathology and
Laboratory Medicine




71 yo M
History of partial thyroidectomy one year ago
Presents with arm weakness
MRI of the spine shows a mass lesion involving C6T1 vertebral bodies and secondary pathologic
fracture


TTF-1
Thyroglobulin
TTF-1
Thyroglobulin

Metastatic follicular thyroid carcinoma
Indianapolis
Central Library




59 yo M
History of “esophageal surgery” one month ago
Presents with cervical vertebral body
“osteomyelitis”
Vertebral body biopsy performed

Squamous cell carcinoma
CK 5/6
 P63
 ?p40

CK cocktail
p63
CK 5/6

Metastatic squamous cell carcinoma, of esophageal
origin




48 yo F
History of breast carcinoma ten years ago
Presents with new onset headaches
Brain MRI shows a left frontal lobe mass


H&E Dx: PD Carcinoma, likely breast
Recommended IHC workup:





CK7/20
GATA-3
GCDFP
Mammaglobin
ER/PR/Her2 (if requested or diagnostically relevant)

CK7 + / CK20 -
CK 20 +
CK 20 -
CK 7 +
Urothelial cell carcinoma
Lung adenocarcinoma
Ovarian mucinous carcinoma Breast carcinoma
Pancreatic adenocarcinoma
Ovarian serous carcinoma
Endometrial adenocarcinoma
Cervical squamous cell ca
Mesothelioma
CK7 -
Colorectal carcinoma
Merkel cell carcinoma
Hepatocellular carcinoma
Renal cell carcinoma
Prostate adenocarcinoma
Squamous cell carcinoma
GATA-3
Her2/neu
Estrogen Receptor

Metastatic breast carcinoma




63 yo F
Presents with headache
Brain MRI shows a left frontal peripherally
enhancing mass with central necrosis located in the
deep white matter
No known history!


H&E Dx: carcinoma, likely renal cell
Recommended IHC workup:


CK7/CK20
Two of the following:
 Vimentin
 EMA
 CD10
 PAX8

CK7 - / CK20 -
CK 20 +
CK 20 -
CK 7 +
Urothelial cell carcinoma
Lung adenocarcinoma
Ovarian mucinous carcinoma Breast carcinoma
Pancreatic adenocarcinoma
Ovarian serous carcinoma
Endometrial adenocarcinoma
Cervical squamous cell ca
Mesothelioma
CK7 -
Colorectal carcinoma
Merkel cell carcinoma
Hepatocellular carcinoma
Renal cell carcinoma
Prostate adenocarcinoma
Squamous cell carcinoma
Vimentin
EMA
CD10
PAX8

Metastatic renal cell carcinoma
Soldiers and Sailors Monument on the Circle




65 yo M
Presents with sacroiliitis, retroperitoneal
adenopathy, and abnormal bone marrow signal in
T1 and T2
Clinical diagnosis: lymphoma
The bone marrow biopsy: initially worked up in
hematopathology



Keratin cocktail
CK7
CK20
Keratin cocktail


CK 7 –
CK 20 –
CK 20 +
CK 20 -
CK 7 +
Urothelial cell carcinoma
Lung adenocarcinoma
Ovarian mucinous carcinoma Breast carcinoma
Pancreatic adenocarcinoma
Ovarian serous carcinoma
Endometrial adenocarcinoma
Cervical squamous cell ca
Mesothelioma
CK7 -
Colorectal carcinoma
Merkel cell carcinoma
Hepatocellular carcinoma
Renal cell carcinoma
Prostate adenocarcinoma
Squamous cell carcinoma
PSAP
PSA
P501S

Metastatic prostatic adenocarcinoma
Bankers Life Fieldhouse



51 yo F
Presented to an outside facility with headache
Imaging studies revealed a right occipital mass with
rim enhancement






Keratin cocktail
CK 7
CK 20
TTF-1
Napsin A
GATA 3
Keratin cocktail
CK7
CK20
CK 20 +
CK 20 -
CK 7 +
Urothelial cell carcinoma
Lung adenocarcinoma
Ovarian mucinous carcinoma Breast carcinoma
Pancreatic adenocarcinoma
Ovarian serous carcinoma
Endometrial adenocarcinoma
Cervical squamous cell ca
Mesothelioma
CK7 -
Colorectal carcinoma
Merkel cell carcinoma
Hepatocellular carcinoma
Renal cell carcinoma
Prostate adenocarcinoma
Squamous cell carcinoma
TTF-1
Napsin A
GATA 3

Metastatic lung adenocarcinoma


57 yo M
Presented with a spontaneous intraparenchymal
hemorrhage in the right temporal lobe


H&E Dx: adenocarcinoma, likely papillary thyroid
Recommended IHC workup:





CK7/20
TTF1
Napsin A
Thyroglobulin
Pax8


CK7 +
CK 20 –
TTF-1
Napsin A


Thyroglobulin +
PAX8 +

Metastatic papillary thyroid carcinoma



56 yo F
Limited past medical history, presented to the
county emergency room with heavy vaginal
bleeding
Imaging studies revealed a large abdominal mass
with extension into and pathologic fracture of the
L3 vertebral body


CK 7
CK 20
CK7
CK20
CK 20 +
CK 20 -
CK 7 +
Urothelial cell carcinoma
Lung adenocarcinoma
Ovarian mucinous carcinoma Breast carcinoma
Pancreatic adenocarcinoma
Ovarian serous carcinoma
Endometrial adenocarcinoma
Cervical squamous cell ca
Mesothelioma
CK7 -
Colorectal carcinoma
Merkel cell carcinoma
Hepatocellular carcinoma
Renal cell carcinoma
Prostate adenocarcinoma
Squamous cell carcinoma
CK 20 +
CK 20 -
CK 7 +
Urothelial cell carcinoma
Lung adenocarcinoma
Ovarian mucinous carcinoma Breast carcinoma
Pancreatic adenocarcinoma
Ovarian serous carcinoma
Endometrial adenocarcinoma
Cervical squamous cell ca
Mesothelioma
CK7 -
Colorectal carcinoma
Merkel cell carcinoma
Hepatocellular carcinoma
Renal cell carcinoma
Prostate adenocarcinoma
Squamous cell carcinoma


TTF1 –
Napsin A –
CK 20 +
CK 20 -
CK 7 +
Urothelial cell carcinoma
Lung adenocarcinoma
Ovarian mucinous carcinoma Breast carcinoma
Pancreatic adenocarcinoma
Ovarian serous carcinoma
Endometrial adenocarcinoma
Cervical squamous cell ca
Mesothelioma
CK7 -
Colorectal carcinoma
Merkel cell carcinoma
Hepatocellular carcinoma
Renal cell carcinoma
Prostate adenocarcinoma
Squamous cell carcinoma
CK 20 +
CK 20 -
CK 7 +
Urothelial cell carcinoma
Lung adenocarcinoma
Ovarian mucinous carcinoma Breast carcinoma
Pancreatic adenocarcinoma
Ovarian serous carcinoma
Endometrial adenocarcinoma
Cervical squamous cell ca
Mesothelioma
CK7 -
Colorectal carcinoma
Merkel cell carcinoma
Hepatocellular carcinoma
Renal cell carcinoma
Prostate adenocarcinoma
Squamous cell carcinoma

GATA3 –

GCDFP-15 –
CK 20 +
CK 20 -
CK 7 +
Urothelial cell carcinoma
Lung adenocarcinoma
Ovarian mucinous carcinoma Breast carcinoma
Pancreatic adenocarcinoma
Ovarian serous carcinoma
Endometrial adenocarcinoma
Cervical squamous cell ca
Mesothelioma
CK7 -
Colorectal carcinoma
Merkel cell carcinoma
Hepatocellular carcinoma
Renal cell carcinoma
Prostate adenocarcinoma
Squamous cell carcinoma
CK 20 +
CK 20 -
CK 7 +
Urothelial cell carcinoma
Lung adenocarcinoma
Ovarian mucinous carcinoma Breast carcinoma
Pancreatic adenocarcinoma
Ovarian serous carcinoma
Endometrial adenocarcinoma
Cervical squamous cell ca
Mesothelioma
CK7 -
Colorectal carcinoma
Merkel cell carcinoma
Hepatocellular carcinoma
Renal cell carcinoma
Prostate adenocarcinoma
Squamous cell carcinoma
WT1
CK 20 +
CK 20 -
CK 7 +
Urothelial cell carcinoma
Lung adenocarcinoma
Ovarian mucinous carcinoma Breast carcinoma
Pancreatic adenocarcinoma
Ovarian serous carcinoma
Endometrial adenocarcinoma
Cervical squamous cell ca
Mesothelioma
CK7 -
Colorectal carcinoma
Merkel cell carcinoma
Hepatocellular carcinoma
Renal cell carcinoma
Prostate adenocarcinoma
Squamous cell carcinoma
CK 20 +
CK 20 -
CK 7 +
Urothelial cell carcinoma
Lung adenocarcinoma
Ovarian mucinous carcinoma Breast carcinoma
Pancreatic adenocarcinoma
Ovarian serous carcinoma
Endometrial adenocarcinoma
Cervical squamous cell ca
Mesothelioma
CK7 -
Colorectal carcinoma
Merkel cell carcinoma
Hepatocellular carcinoma
Renal cell carcinoma
Prostate adenocarcinoma
Squamous cell carcinoma


BER-EP4 +
MOC-31 +
CK 20 +
CK 20 -
CK 7 +
Urothelial cell carcinoma
Lung adenocarcinoma
Ovarian mucinous carcinoma Breast carcinoma
Pancreatic adenocarcinoma
Ovarian serous carcinoma
Endometrial adenocarcinoma
Cervical squamous cell ca
Mesothelioma
CK7 -
Colorectal carcinoma
Merkel cell carcinoma
Hepatocellular carcinoma
Renal cell carcinoma
Prostate adenocarcinoma
Squamous cell carcinoma
CK 20 +
CK 20 -
CK 7 +
Urothelial cell carcinoma
Lung adenocarcinoma
Ovarian mucinous carcinoma Breast carcinoma
Pancreatic adenocarcinoma
Ovarian serous carcinoma
Endometrial adenocarcinoma
Cervical squamous cell ca
Mesothelioma
CK7 -
Colorectal carcinoma
Merkel cell carcinoma
Hepatocellular carcinoma
Renal cell carcinoma
Prostate adenocarcinoma
Squamous cell carcinoma
Estrogen receptor
CK 20 +
CK 20 -
CK 7 +
Urothelial cell carcinoma
Lung adenocarcinoma
Ovarian mucinous carcinoma Breast carcinoma
Pancreatic adenocarcinoma
Ovarian serous carcinoma
Endometrial adenocarcinoma
Cervical squamous cell ca
Mesothelioma
CK7 -
Colorectal carcinoma
Merkel cell carcinoma
Hepatocellular carcinoma
Renal cell carcinoma
Prostate adenocarcinoma
Squamous cell carcinoma

CDX2 +!

Caveat: CDX2 may be aberrantly expressed in
endometrial adenocarcinoma!

Metastatic endometrial adenocarcinoma


65 yo M
Presented with new onset seizures






CK AE1/3
EMA
PR
CK7
CK20
p63

Reactive Immunostains





Ki67
PR
AE1/AE3
P63
EMA

Negative Immunostains
Synaptophysin
 GFAP
 CDX2
 CK5/6
 CD45RB
 S100 protein
 CK20
 CK7
 CD34
 Napsin A

CK AE1/3
EMA
Progesterone Receptor
CK 7
CK 20
p63

Metastatic lung squamous cell carcinoma???

similar documents